Suda Koichi, Nobukawa Bunsei, Yamasaki Shigetaka, Abe Keiko, Matsukuma Susumu, Suzuki Fujihiko
Department of Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Tokyo 113-8421, Japan.
J Hepatobiliary Pancreat Surg. 2007;14(3):283-8. doi: 10.1007/s00534-006-1137-x. Epub 2007 May 29.
BACKGROUND/PURPOSE: We aimed to elucidate the origin/primary site of invasive ductal adenocarcinoma of the pancreas, based on the distribution of intraductal carcinoma components. These components were identified by a mural elastic fiber cuff.
Thirteen specimens from patients with invasive ductal adenocarcinoma (microscopically, less than 2 cm in diameter) of the pancreas were studied histopathologically. Variants of invasive ductal adenocarcinoma and intraductal papillary-mucinous carcinoma were excluded.
Intraductal carcinoma components of invasive ductal adenocarcinoma were found in 12 of the specimens 13 (92%), and were observed within the tumor mass and/or on its boundary, or outside the tumor mass. Intraductal components were characterized by low papillary projections lacking a fibrovascular core, with/without surrounding tubular structures, or by irregular stratification and pleomorphism of the epithelial cells. Invasive components mostly showed a tubular pattern with desmoplasia. The distribution of the intraductal components in the 12 specimens was as follows: in 9 (75%), they were in both the main pancreatic duct and large branch ducts; and in 3, they were in the smaller branch ducts only.
Invasive ductal adenocarcinomas of the pancreas may originate most frequently from the main pancreatic duct or larger branch ducts, while the smaller ducts are less often the site of cancer origin.
背景/目的:基于导管内癌成分的分布情况,我们旨在阐明胰腺浸润性导管腺癌的起源/原发部位。这些成分通过壁弹性纤维套来识别。
对13例胰腺浸润性导管腺癌(显微镜下直径小于2厘米)患者的标本进行组织病理学研究。排除浸润性导管腺癌和导管内乳头状黏液性癌的变异型。
13例标本中有12例(92%)发现了浸润性导管腺癌的导管内癌成分,这些成分在肿瘤块内和/或其边界处,或在肿瘤块外被观察到。导管内成分的特征是缺乏纤维血管核心的低乳头状突起,有/无周围管状结构,或上皮细胞的不规则分层和多形性。浸润性成分大多表现为伴有促纤维增生的管状模式。12例标本中导管内成分的分布如下:9例(75%)同时存在于主胰管和大分支导管中;3例仅存在于较小的分支导管中。
胰腺浸润性导管腺癌最常起源于主胰管或较大的分支导管,而较小的导管较少成为癌症起源部位。